Article info

Original research
Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer

Authors

  • Xu Cao Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Duarte, California, USA PubMed articlesGoogle scholar articles
  • Bolei Li Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Duarte, California, USA PubMed articlesGoogle scholar articles
  • Jing Chen Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Duarte, California, USA PubMed articlesGoogle scholar articles
  • Jessica Dang Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Duarte, California, USA PubMed articlesGoogle scholar articles
  • Siqi Chen Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Duarte, California, USA PubMed articlesGoogle scholar articles
  • E Gulsen Gunes Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Duarte, California, USADepartment of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA PubMed articlesGoogle scholar articles
  • Bo Xu Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Duarte, California, USADepartment of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA PubMed articlesGoogle scholar articles
  • Lei Tian Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Duarte, California, USADepartment of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA PubMed articlesGoogle scholar articles
  • Sabina Muend Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Duarte, California, USA PubMed articlesGoogle scholar articles
  • Mustafa Raoof Department of Surgery, City of Hope, Duarte, California, USA PubMed articlesGoogle scholar articles
  • Christiane Querfeld Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Duarte, California, USADepartment of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USADivision of Dermatology, City of Hope, Duarte, California, USADepartment of Pathology, City of Hope, Duarte, California, USA PubMed articlesGoogle scholar articles
  • Jianhua Yu Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Duarte, California, USADepartment of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USAHematologic Malignancies and Stem Cell Transplantation Institute, City of Hope, Duarte, California, USA PubMed articlesGoogle scholar articles
  • Steven T. Rosen Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USABeckman Research Institute, City of Hope, Duarte, California, USA PubMed articlesGoogle scholar articles
  • Yingyu Wang Center for Informatics, City of Hope, Duarte, California, USA PubMed articlesGoogle scholar articles
  • Mingye Feng Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Duarte, California, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Mingye Feng; mfeng{at}coh.org
View Full Text

Citation

Cao X, Li B, Chen J, et al
Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer

Publication history

  • Accepted February 4, 2021
  • First published March 22, 2021.
Online issue publication 
March 22, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.